RVL Pharmaceuticals (FRA:O1P) Change In Receivables : €-0.20 Mil (TTM As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is RVL Pharmaceuticals Change In Receivables?

RVL Pharmaceuticals's change in receivables for the quarter that ended in Jun. 2023 was €-0.05 Mil. It means RVL Pharmaceuticals's Accounts Receivable increased by €0.05 Mil from Mar. 2023 to Jun. 2023 .

RVL Pharmaceuticals's change in receivables for the fiscal year that ended in Dec. 2022 was €-0.85 Mil. It means RVL Pharmaceuticals's Accounts Receivable increased by €0.85 Mil from Dec. 2021 to Dec. 2022 .

RVL Pharmaceuticals's Accounts Receivable for the quarter that ended in Jun. 2023 was €0.93 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. RVL Pharmaceuticals's Days Sales Outstanding for the three months ended in Jun. 2023 was 11.09.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. RVL Pharmaceuticals's liquidation value for the three months ended in Jun. 2023 was €-44.75 Mil.

RVL Pharmaceuticals Change In Receivables Historical Data

The historical data trend for RVL Pharmaceuticals's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RVL Pharmaceuticals Change In Receivables Chart

RVL Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Receivables

Get a 7-Day Free Trial

-14.98

11.41

14.38

6.29

-0.85

RVL Pharmaceuticals Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Change In Receivables	Get a 7-Day Free Trial															14.89	-1.46	0.24	1.08	-0.05

RVL Pharmaceuticals Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.20 Mil.

RVL Pharmaceuticals (FRA:O1P) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

RVL Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.926	/	7.622	*	91
=	11.09

2. In Ben Graham's calculation of liquidation value, RVL Pharmaceuticals's accounts receivable are only considered to be worth 75% of book value:

RVL Pharmaceuticals's liquidation value for the quarter that ended in Jun. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	17.684	-	63.759	+	0.75 * 0.926	+	0.5 * 1.252
=	-44.75

RVL Pharmaceuticals Change In Receivables Related Terms

Thank you for viewing the detailed overview of RVL Pharmaceuticals's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

RVL Pharmaceuticals (FRA:O1P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RVL Pharmaceuticals PLC (FRA:O1P) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

RVLPQ:USA

Address

400 Crossing Boulevard, Bridgewater, NJ, USA, 08807

Website

https://www.rvlpharma.com

RVL Pharmaceuticals PLC is a pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular medicine and medical aesthetics therapeutic areas. Its revenues consist of product sales, royalty revenues and licensing revenue.

RVL Pharmaceuticals (FRA:O1P) Headlines

No Headlines